661 related articles for article (PubMed ID: 12472324)
1. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
Corwin HL; Gettinger A; Rodriguez RM; Pearl RG; Gubler KD; Enny C; Colton T; Corwin MJ
Crit Care Med; 1999 Nov; 27(11):2346-50. PubMed ID: 10579246
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of epoetin alfa in critically ill patients.
Corwin HL; Gettinger A; Fabian TC; May A; Pearl RG; Heard S; An R; Bowers PJ; Burton P; Klausner MA; Corwin MJ;
N Engl J Med; 2007 Sep; 357(10):965-76. PubMed ID: 17804841
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
6. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
Voils SA; Harpe SH; Brophy GM
Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
MacLaren R; Sullivan PW
Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
[TBL] [Abstract][Full Text] [Related]
8. Anemia and blood transfusion in the critically ill patient: role of erythropoietin.
Corwin HL
Crit Care; 2004; 8 Suppl 2():S42-4. PubMed ID: 15196323
[TBL] [Abstract][Full Text] [Related]
9. The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.
Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Abraham E; MacIntyre NR; Shabot MM; Duh MS; Shapiro MJ
Crit Care Med; 2004 Jan; 32(1):39-52. PubMed ID: 14707558
[TBL] [Abstract][Full Text] [Related]
10. A US multicenter, retrospective, observational study of erythropoiesis-stimulating agent utilization in anemic, critically ill patients admitted to the intensive care unit.
Brophy GM; Sheehan V; Shapiro MJ; Lottenberg L; Scarlata D; Audhya P;
Clin Ther; 2008 Dec; 30(12):2324-34. PubMed ID: 19167591
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
12. Anemia and blood transfusion in critically ill patients.
Vincent JL; Baron JF; Reinhart K; Gattinoni L; Thijs L; Webb A; Meier-Hellmann A; Nollet G; Peres-Bota D;
JAMA; 2002 Sep; 288(12):1499-507. PubMed ID: 12243637
[TBL] [Abstract][Full Text] [Related]
13. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
[TBL] [Abstract][Full Text] [Related]
14. Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR
Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
[TBL] [Abstract][Full Text] [Related]
15. Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.
Holst LB
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836806
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317].
Georgopoulos D; Matamis D; Routsi C; Michalopoulos A; Maggina N; Dimopoulos G; Zakynthinos E; Nakos G; Thomopoulos G; Mandragos K; Maniatis A;
Crit Care; 2005 Oct; 9(5):R508-15. PubMed ID: 16277712
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study.
Katsios C; Griffith L; Spinella P; Lacroix J; Crowther M; Hebert P; Meade M; Geerts W; Rabbat C; Cook D
Crit Care; 2011; 15(6):R263. PubMed ID: 22044745
[TBL] [Abstract][Full Text] [Related]
19. Use of exogenous erythropoietin in critically ill patients.
MacLaren R; Gasper J; Jung R; Vandivier RW
J Clin Pharm Ther; 2004 Jun; 29(3):195-208. PubMed ID: 15153081
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
